BioMark Diagnostics, Inc.: BioMark to Present New Cancer Screening Data Using the LDTD-MS/MS Technique at the Annual ASMS Conference on Mass Spectrometry
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2022) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on hard
United States Minneapolis Convention Center United Kingdom British Columbia Rashid Bux Rashid Ahmed Bux
Source: finanznachrichten.de